Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study

Autor: Karampeazis, Athanasios, Vamvakas, Lambros, Kotsakis, Athanasios, Christophyllakis, Charalambos, Kentepozidis, Nikolaos, Chandrinos, Vassilios, Agelidou, Anna, Polyzos, Aris, Tsiafaki, Xanthi, Hatzidaki, Dora, Georgoulias, Vassilis
Zdroj: In Journal of Geriatric Oncology January 2017 8(1):23-30
Databáze: ScienceDirect